KALEIDO BIOSCIENCES, INC. Stock-Based Compensation
KALEIDO BIOSCIENCES, INC. reported Stock-Based Compensation of $10.34 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2022-04-01
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2021-12-31 was $1.71M, a 38.71% decline year-over-year.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2021-09-30 was $2.03M, a 53.41% decline year-over-year.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2021-06-30 was $2.38M, a 15.63% decline year-over-year.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for the quarter ending 2021-03-31 was $4.23M, a 55.19% increase year-over-year.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $10.34M, a 18.46% decline from fiscal 2020.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $12.68M, a 25.98% increase from fiscal 2019.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $10.07M, a 44.57% increase from fiscal 2018.
- KALEIDO BIOSCIENCES, INC. share-based payment arrangement, noncash expense for fiscal 2018 was $6.96M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2021-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | $3.74M derived: sum of 2 quarters · filed 2022-04-01 | $6.11M derived: sum of 3 quarters · filed 2022-04-01 | $10.34M 10-K · filed 2022-04-01 |
| 2021-09-30 | $2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $4.41M derived: sum of 2 quarters · filed 2021-11-01 | $8.64M 10-Q · filed 2021-11-01 | $11.42M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-06-30 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $6.61M 10-Q · filed 2021-08-11 | $9.39M derived: sum of 3 quarters · filed 2022-04-01 | $13.75M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-03-31 | $4.23M 10-Q · filed 2021-05-04 | $7.01M derived: sum of 2 quarters · filed 2022-04-01 | $11.37M derived: sum of 3 quarters · filed 2022-04-01 | $14.19M derived: sum of 4 quarters · filed 2022-04-01 |
| 2020-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | $7.14M derived: sum of 2 quarters · filed 2022-04-01 | $9.96M derived: sum of 3 quarters · filed 2022-04-01 | $12.68M 10-K · filed 2022-04-01 |
| 2020-09-30 | $4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $7.18M derived: sum of 2 quarters · filed 2021-11-01 | $9.90M 10-Q · filed 2021-11-01 | $12.13M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | $2.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $5.54M 10-Q · filed 2021-08-11 | $7.77M derived: sum of 3 quarters · filed 2021-08-11 | $10.68M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $2.73M 10-Q · filed 2021-05-04 | $4.96M derived: sum of 2 quarters · filed 2021-05-04 | $7.87M derived: sum of 3 quarters · filed 2021-05-04 | $10.27M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $5.14M derived: sum of 2 quarters · filed 2021-03-03 | $7.54M derived: sum of 3 quarters · filed 2021-03-03 | $10.07M 10-K · filed 2021-03-03 |
| 2019-09-30 | $2.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $5.31M derived: sum of 2 quarters · filed 2020-11-02 | $7.84M 10-Q · filed 2020-11-02 | $10.24M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $4.93M 10-Q · filed 2020-08-04 | $7.33M derived: sum of 3 quarters · filed 2020-08-04 | $11.15M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $2.53M 10-Q · filed 2020-05-14 | $4.93M derived: sum of 2 quarters · filed 2020-05-14 | $8.76M derived: sum of 3 quarters · filed 2020-05-14 | $9.26M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $6.23M derived: sum of 2 quarters · filed 2020-03-02 | $6.73M derived: sum of 3 quarters · filed 2020-03-02 | $6.96M 10-K · filed 2020-03-02 |
| 2018-09-30 | $3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $4.33M derived: sum of 2 quarters · filed 2019-10-30 | $4.56M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $503.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $737.00K 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $234.00K 10-Q · filed 2019-05-02 |